These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36250711)

  • 21. Tissue damage detected by quantitative gradient echo MRI correlates with clinical progression in non-relapsing progressive MS.
    Xiang B; Brier MR; Kanthamneni M; Wen J; Snyder AZ; Yablonskiy DA; Cross AH
    Mult Scler; 2022 Sep; 28(10):1515-1525. PubMed ID: 35196933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS.
    Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Rovira À; Montalban X; Kearney H; Ciccarelli O; Matthews L; Palace J; Gallo A; Bisecco A; Gass A; Eisele P; Lukas C; Bellenberg B; Barkhof F; Vrenken H; Preziosa P; Comi G; Filippi M;
    Neurology; 2019 Nov; 93(20):e1852-e1866. PubMed ID: 31611336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of cortical grey matter thickness reduction in multiple sclerosis.
    Fujimori J; Fujihara K; Wattjes M; Nakashima I
    Brain Behav; 2021 Apr; 11(4):e02050. PubMed ID: 33506628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemispheric asymmetry measured by texture analysis and diffusion tensor imaging in two multiple sclerosis subtypes.
    Savio S; Hakulinen U; Ryymin P; Hagman S; Dastidar P; Soimakallio S; Elovaara I; Eskola H
    Acta Radiol; 2015 Jul; 56(7):844-51. PubMed ID: 25024438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and MRI predictors of cognitive decline in patients with relapsing-remitting multiple sclerosis: A 2-year longitudinal study.
    Dong X; Xu G; Wang J; Yin N; Meng N
    Mult Scler Relat Disord; 2022 Sep; 65():103838. PubMed ID: 35749960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal cortical thinning progression differs across multiple sclerosis phenotypes and is clinically relevant: A multicentre study.
    Hidalgo de la Cruz M; Valsasina P; Gobbi C; Gallo A; Zecca C; Bisecco A; Tedeschi G; Filippi M; Rocca MA
    Mult Scler; 2021 May; 27(6):827-840. PubMed ID: 32662748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No regional gray matter atrophy differences between pediatric- and adult-onset relapsing-remitting multiple sclerosis.
    Donohue K; Cox JL; Dwyer MG; Aliotta R; Corwin M; Weinstock-Guttman B; Ann Yeh E; Zivadinov R
    J Neuroimaging; 2014; 24(1):63-7. PubMed ID: 23317029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between symbol digit modalities test and regional cortex thickness in young adults with relapsing-remitting multiple sclerosis.
    Tao Y; XueSong Z; Xiao Y; YueZhi K; Xin W; YanPing T; Lei W; YongPing F
    Clin Neurol Neurosurg; 2021 Aug; 207():106805. PubMed ID: 34280674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study.
    Hidalgo de la Cruz M; Valsasina P; Meani A; Gallo A; Gobbi C; Bisecco A; Tedeschi G; Zecca C; Rocca MA; Filippi M
    Mult Scler; 2022 Mar; 28(3):406-417. PubMed ID: 34124963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of transorbital sonography measures of optic nerve diameter in the context of global and regional brain volume in multiple sclerosis.
    Antal SI; Kincses B; Veréb D; Király A; Tóth E; Bozsik B; Faragó P; Szabó N; Kocsis K; Bencsik K; Klivényi P; Kincses ZT
    Sci Rep; 2023 Apr; 13(1):5578. PubMed ID: 37019969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preferential spinal cord volume loss in primary progressive multiple sclerosis.
    Tsagkas C; Magon S; Gaetano L; Pezold S; Naegelin Y; Amann M; Stippich C; Cattin P; Wuerfel J; Bieri O; Sprenger T; Kappos L; Parmar K
    Mult Scler; 2019 Jun; 25(7):947-957. PubMed ID: 29781383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole brain and deep gray matter atrophy detection over 5 years with 3T MRI in multiple sclerosis using a variety of automated segmentation pipelines.
    Chu R; Kim G; Tauhid S; Khalid F; Healy BC; Bakshi R
    PLoS One; 2018; 13(11):e0206939. PubMed ID: 30408094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormalcortical thickness in relapsing-remitting multiple sclerosis, correlations with cognition impairment, and effect of modified Bushenyisui decoction on cognitive function of multiple sclerosis.
    Zhao X; Yang T; Cheng F; Yang S; Zhu W; Li S; Fan Y
    J Tradit Chin Med; 2021 Apr; 41(2):316-325. PubMed ID: 33825413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stratification of multiple sclerosis patients using unsupervised machine learning: a single-visit MRI-driven approach.
    Pontillo G; Penna S; Cocozza S; Quarantelli M; Gravina M; Lanzillo R; Marrone S; Costabile T; Inglese M; Morra VB; Riccio D; Elefante A; Petracca M; Sansone C; Brunetti A
    Eur Radiol; 2022 Aug; 32(8):5382-5391. PubMed ID: 35284989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central nervous system atrophy predicts future dynamics of disability progression in a real-world multiple sclerosis cohort.
    Tsagkas C; Naegelin Y; Amann M; Papadopoulou A; Barro C; Chakravarty MM; Gaetano L; Wuerfel J; Kappos L; Kuhle J; Granziera C; Sprenger T; Magon S; Parmar K
    Eur J Neurol; 2021 Dec; 28(12):4153-4166. PubMed ID: 34487400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leptomeningeal Contrast Enhancement Is Related to Focal Cortical Thinning in Relapsing-Remitting Multiple Sclerosis: A Cross-Sectional MRI Study.
    Bergsland N; Ramasamy D; Tavazzi E; Hojnacki D; Weinstock-Guttman B; Zivadinov R
    AJNR Am J Neuroradiol; 2019 Apr; 40(4):620-625. PubMed ID: 30872420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between cognitive and clinical disability across MS subtypes: The role of the underlying brain damage.
    Gois LCP; Pimentel-Silva LR; Damasceno BP; Damasceno A
    Mult Scler Relat Disord; 2021 Feb; 48():102701. PubMed ID: 33477004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deep learning of joint myelin and T1w MRI features in normal-appearing brain tissue to distinguish between multiple sclerosis patients and healthy controls.
    Yoo Y; Tang LYW; Brosch T; Li DKB; Kolind S; Vavasour I; Rauscher A; MacKay AL; Traboulsee A; Tam RC
    Neuroimage Clin; 2018; 17():169-178. PubMed ID: 29071211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced diffusion-weighted imaging models better characterize white matter neurodegeneration and clinical outcomes in multiple sclerosis.
    Storelli L; Pagani E; Meani A; Preziosa P; Filippi M; Rocca MA
    J Neurol; 2022 Sep; 269(9):4729-4741. PubMed ID: 35397753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct regional brain atrophy pattern in multiple sclerosis and neuropsychiatric systemic lupus erythematosus patients.
    Kalinowska-Lyszczarz A; Pawlak MA; Pietrzak A; Pawlak-Bus K; Leszczynski P; Puszczewicz M; Paprzycki W; Kozubski W; Michalak S
    Lupus; 2018 Sep; 27(10):1624-1635. PubMed ID: 29950159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.